Cerapedics Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 250

Employees

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $2.34M

  • Investors
  • 6

Cerapedics General Information

Description

Developer of ortho-biological technology intended to provide bone graft substitute for use in spinal fusion surgery and other orthopedic procedures. The company's technology is focused on developing and commercializing novel biologic products that incorporate a small peptide as an attachment factor to stimulate the natural bone healing process, enabling physicians to support safer and predictable bone formation compared to commercially available bone growth factors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Surgical Devices
Discovery Tools (Healthcare)
Corporate Office
  • 11025 Dover Street
  • Suite 1600
  • Westminster, CO 80021
  • United States
+1 (303) 000-0000

Cerapedics Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cerapedics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Debt - General 30-Sep-2023 $2.34M 00000 Completed Generating Revenue
14. Debt - General 27-Dec-2022 000.00 00000 Completed Generating Revenue
13. Later Stage VC (Series F) 18-Feb-2022 00000 00000 00000 Completed Generating Revenue
12. Secondary Transaction - Private 01-Aug-2021 00000 Completed Generating Revenue
11. Debt - General 22-Mar-2019 000.00 00000 Completed Generating Revenue
10. Later Stage VC (Series E) 06-Jul-2018 0000 00000 00000 Completed Generating Revenue
9. Debt - General 19-Apr-2017 0000 00000 Completed Generating Revenue
8. Later Stage VC (Series D) 23-Sep-2016 0000 000.00 0000 Completed Generating Revenue
7. Debt - General 22-Apr-2016 $7.63M $73.1M Completed Generating Revenue
6. Later Stage VC (Series C) 23-Feb-2015 $8M $65.5M 000.00 Completed Generating Revenue
To view Cerapedics’s complete valuation and funding history, request access »

Cerapedics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series F 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series E 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00 00.00 00.00 00 00.00 0.00
Series C 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series B 13,256,314 $0.010000 7% $1.37 $1.37 1x $1.37 10.68%
Series A 14,457,000 $0.010000 7% $1 $1 1x $1 11.65%
To view Cerapedics’s complete cap table history, request access »

Cerapedics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of ortho-biological technology intended to provide bone graft substitute for use in spinal fusion surgery and
Biotechnology
Westminster, CO
250 As of 2024
00000
000000000 00000

000000

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
00000000 0000000
East Providence, RI
00 As of 0000
000.00
000000000000 000.00

000000

dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident
00000000 0000000
Fremont, CA
0 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cerapedics Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
IlluminOss Private Equity-Backed East Providence, RI 00 000.00 000000000000 000.00
Encoll Corporation Fremont, CA 0
MicroCures Venture Capital-Backed Santa Cruz, CA 0 00.00 0000000000 0 00.00
Spine Wave Venture Capital-Backed Shelton, CT 000 00000 00000000000 00000
Organovo Formerly VC-backed San Diego, CA 00 0000 00000000 0000
You’re viewing 5 of 15 competitors. Get the full list »

Cerapedics Patents

Cerapedics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11235086-B2 Processes for coating inorganic particles with a peptide or protein useful for improving cellular activity related to bone growth Active 22-Feb-2018 000000000 00
US-20200030488-A1 Processes for coating inorganic particles with a peptide or protein useful for improving cellular activity related to bone growth Active 22-Feb-2018 000000000
EP-3530294-A1 Processes for coating inorganic particles with a peptide or protein useful for improving cellular activity related to bone growth Inactive 22-Feb-2018 000000000 0
AU-2017301511-B2 Peptide-coated calcium phosphate particles Active 25-Jul-2016 000000000 0
AU-2017301511-A1 Peptide-coated calcium phosphate particles Active 25-Jul-2016 A61K35/32
To view Cerapedics’s complete patent history, request access »

Cerapedics Executive Team (27)

Name Title Board Seat Contact Info
Jeffrey Marx Ph.D Chief Scientific Officer
Mani Gopal Ph.D Chief Operating Officer
Andy Woods Director Of Commercial Development - EMEA
Katie Davis Director, Research & Development
Matt Thomas Chief Commercial Officer
You’re viewing 5 of 27 executive team members. Get the full list »

Cerapedics Board Members (15)

Name Representing Role Since
Andrew Tofe Ph.D Cerapedics Founder & Board Member 000 0000
Antony Koblish Self Chairman 000 0000
Douglas Kohrs Self Board Member 000 0000
Gregory Garfield JD KCK Group Board Member 000 0000
Kenneth Abramowitz NGN Capital Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Cerapedics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cerapedics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Miraki Innovation Venture Capital Minority 000 0000 000000 0
KCK Group Family Office Minority 000 0000 000000 0
KCK MedTech Venture Capital Minority 000 0000 000000 0
Revelation Partners Venture Capital Minority 000 0000 000000 0
NGN Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Cerapedics FAQs

  • When was Cerapedics founded?

    Cerapedics was founded in 2001.

  • Who is the founder of Cerapedics?

    Andrew Tofe Ph.D is the founder of Cerapedics.

  • Who is the CEO of Cerapedics?

    Valeska Schroeder Ph.D is the CEO of Cerapedics.

  • Where is Cerapedics headquartered?

    Cerapedics is headquartered in Westminster, CO.

  • What is the size of Cerapedics?

    Cerapedics has 250 total employees.

  • What industry is Cerapedics in?

    Cerapedics’s primary industry is Biotechnology.

  • Is Cerapedics a private or public company?

    Cerapedics is a Private company.

  • What is Cerapedics’s current revenue?

    The current revenue for Cerapedics is 000000.

  • How much funding has Cerapedics raised over time?

    Cerapedics has raised $344M.

  • Who are Cerapedics’s investors?

    Miraki Innovation, KCK Group, KCK MedTech, Revelation Partners, and NGN Capital are 5 of 6 investors who have invested in Cerapedics.

  • Who are Cerapedics’s competitors?

    IlluminOss, Encoll, MicroCures, Spine Wave, and Organovo are some of the 15 competitors of Cerapedics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »